Astellas Pharma | 4503 - Operating Expenses


Astellas Pharma reported JPY455.56B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Astellas Pharma JPY 455.56B 33.8B Jun/2026
Chugai Pharma JPY 201.8B 21.07B Sep/2026
Daiichi Sankyo JPY 489.64B 21.08B Jun/2026
Eisai JPY 209.6B 6.14B Jun/2026
Kyowa Hakko Kirin JPY 122.9B 13.95B Jun/2026
M3 JPY 73.56B 2.76B Jun/2026
Otsuka Holdings JPY 561.64B 49.51B Jun/2026
Shionogi JPY 96.4B 24.61B Jun/2026
Sumitomo Dainippon JPY 111.74B 2.64B Jun/2026
Takeda JPY 981.78B 36.71B Sep/2026
Terumo JPY 222.33B 46.54B Jun/2026